// App-Quantinova.ai

: A global perspective on acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF): results from an international survey

Researchers

Presenter

  • Michael Kreuter

Principal Investigators

  • Simon Walsh

  • Harold R Collard

  • Nazia Chaudhuri

  • Sergey Avdeev

  • Juergen Behr

  • Greg Calligero

  • Tamera Corte

  • Kevin Flaherty

  • Manuela Funke

  • Martin Kolb

  • Yasuhiro Kondoh

  • Toby M. Maher

  • Maria Molina Molina

  • Antonio Morais

  • Karen Moor

  • Julie Morisset

  • Carlos Pereira

  • Silvia Quadrelli

  • Moises Selman

  • Argyrios Tzouvelekis

  • Carlo Vancheri

  • Vanesa Vicens-Zygmunt

  • Julia Waelscher

  • Wim Wuyts

  • Marlies Wijsenbeek

  • Vincent Cottin

  • Elisabeth Bendstrup

Medical Centers

  • Center for Interstitial and Rare Lung Diseases, Thoraxklinik, University of Heidelberg and German Center for Lung Research, Heidelberg, Germany

  • Center for interstitial and rare lung diseases, Thoraxklinik, University Hospital Heidelberg, Heidelberg, Germany

  • King's College Hosptial NHS Foundation Trust, London, United Kingdom

  • University of California–San Francisco - California - United States of America

  • Lancaster University, Lancaster, United Kingdom

  • Pulmonary Research Institute, Moscow, Russian Federation.

  • Medical Clinic V, University of Munic, Germany, German Center for Lung Research and Fachkliniken München, Gauting, Germany

  • Division of Pulmonology, Department of Medicine, University of Cape Town, Cape Town, South Africa,

  • University of Michigan Health System, Ann Arbor, MI, United States,

  • Department of Radiation Oncology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland

  • Division of Neonatology, Department of Pediatrics, McMaster University, Hamilton, ON, Canada

  • Department of Respiratory Medicine and Allergy, Tosei General Hospital, Nagoya University School of Medicine, Aichi, Japan

  • National Institute for Health Research Respiratory Biomedical Research Unit Royal Brompton Hospital London, United Kingdom and National Heart and Lung Institute Imperial College London, London, United Kingdom

  • Servei de Pneumologia, Hospital Clinic, Barcelona, Spain

  • Department of Pneumology, Centro Hospitalar de Sao Joao, Porto, Portugal

  • Department of Respiratory Medicine, Erasmus University Hospital Rotterdam, Rotterdam, Netherlands,

  • Interstitial Lung Diseases Program, Federal University of São Paulo, São Paulo, Brazil

  • Buenos Aires British Hospital, Buenos Aires, Argentina

  • Instituto Nacional de Enfermedades Respiratorias (INER) Ismael Cosio Villegas., Mexico City, Mexico

  • First Academic Department of Pneumonology, Hospital for Diseases of the Chest, "Sotiria", Medical School, University of Athens, Greece; Division of Immunology, Biomedical Sciences Research Center "Alexander Fleming, Athens, Greece

  • Regional Referral Centre for Rare Lung Diseases, University Hospital "Policlinico", Department of Clinical and Respiratory Medicine, University of Catania, Catania, Italy

  • Unit for Interstitial Lung Diseases, Department of Respiratory Medicine, University Hospitals Leuven, Leuven, Belgium,

  • HCL - Université Lyon, Lyon, France

  • Department of Respiratory Diseases and Allergology, Aarhus University Hospital, Aarhus, Denmark.

Locations

  • Germany

  • United Kingdom

  • United States

  • Russia

  • South Africa

  • Australia

  • Switzerland

  • Canada

  • Japan

  • Spain

  • Portugal

  • Netherlands

  • Brazil

  • Argentina

  • Mexico

  • Greece

  • Italy

  • Belgium

  • France

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Idiopathic pulmonary fibrosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved